Feedback / Questions
ATRC-101 - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2022/10/05/2529056/0/en/Atreca-Announces-Poster-Presentations-at-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
Oct 5, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next